Rafael starts Phase III trial of CPI-613 and CHAM to treat AML
Rafael Pharmaceuticals has commenced the Phase lll ARMADA 2000 trial to investigate the efficacy and...
Rafael Pharmaceuticals has commenced the Phase lll ARMADA 2000 trial to investigate the efficacy and...